APO Research
Talk to an analyst

APO RESEARCH · REPORT

Passive Immunizing Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Passive Immunizing Drugs Market Analysis and Forecast 2026-2032

27 December 2025204 pages

Choose your research edition.

Industry ResearchPassive Immunizing Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Passive Immunizing Drugs Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Passive Immunizing Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Passive Immunizing Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Passive Immunizing Drugs Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Passive Immunizing Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Passive Immunizing Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Passive Immunizing Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Passive Immunizing Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Passive Immunizing Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Passive Immunizing Drugs include Xingmeng Biopharmaceuticals (Suzhou), Wuhan Institute of Biological Products, Sichuan Yuanda Shuyang Pharmaceutical, Shanxi Kangbao Biological Product, Sharon Bio-Medicine, Hualan Biological Engineering, North China Pharmaceutical, Sinopharm Group and Zydus Lifesciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Passive Immunizing Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Passive Immunizing Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Passive Immunizing Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Passive Immunizing Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Passive Immunizing Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Passive Immunizing Drugs sales, projected growth trends, production technology, application and end-user industry.

Passive Immunizing Drugs Segment by Company

Xingmeng Biopharmaceuticals (Suzhou)

Wuhan Institute of Biological Products

Sichuan Yuanda Shuyang Pharmaceutical

Shanxi Kangbao Biological Product

Sharon Bio-Medicine

Hualan Biological Engineering

North China Pharmaceutical

Sinopharm Group

Zydus Lifesciences

Serum Institute of India

Sanofi Pasteur

Kedrion Biopharma

Kamada

Haffkine Bio-Pharmaceutical

Grifols

Bharat Biotech

Passive Immunizing Drugs Segment by Type

Rabies Immunoglobulin

Rabies Virus Monoclonal Antibody

Anti-rabies Serum

Passive Immunizing Drugs Segment by Application

Category II Exposure

Category III Exposure

Passive Immunizing Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Passive Immunizing Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Passive Immunizing Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Passive Immunizing Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Passive Immunizing Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Passive Immunizing Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Passive Immunizing Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Passive Immunizing Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rabies Immunoglobulin Major Manufacturers Table 3. Rabies Virus Monoclonal Antibody Major Manufacturers Table 4. Anti-rabies Serum Major Manufacturers Table 5. Global Passive Immunizing Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Category II Exposure Major Manufacturers Table 7. Category III Exposure Major Manufacturers Table 8. Passive Immunizing Drugs Industry Trends Table 9. Passive Immunizing Drugs Industry Drivers Table 10. Passive Immunizing Drugs Industry Opportunities and Challenges Table 11. Passive Immunizing Drugs Industry Restraints Table 12. Global Passive Immunizing Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Passive Immunizing Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Passive Immunizing Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Passive Immunizing Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Passive Immunizing Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Passive Immunizing Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Passive Immunizing Drugs Sales by Region (2021-2026) & (K Units) Table 19. Global Passive Immunizing Drugs Sales by Region (2027-2032) & (K Units) Table 20. Global Passive Immunizing Drugs Sales Market Share by Region (2021-2026) Table 21. Global Passive Immunizing Drugs Sales Market Share by Region (2027-2032) Table 22. Global Passive Immunizing Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Passive Immunizing Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Passive Immunizing Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Passive Immunizing Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Passive Immunizing Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Passive Immunizing Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Passive Immunizing Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Passive Immunizing Drugs Manufacturers, Product Type & Application Table 30. Global Passive Immunizing Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Passive Immunizing Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Passive Immunizing Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Passive Immunizing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Passive Immunizing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Passive Immunizing Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Passive Immunizing Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Passive Immunizing Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 40. Global Passive Immunizing Drugs Sales by Type (2027-2032) & (K Units) Table 41. Global Passive Immunizing Drugs Sales Market Share by Type (2021-2026) Table 42. Global Passive Immunizing Drugs Sales Market Share by Type (2027-2032) Table 43. Global Passive Immunizing Drugs Price by Type (2021-2026) & (US$/Unit) Table 44. Global Passive Immunizing Drugs Price by Type (2027-2032) & (US$/Unit) Table 45. Global Passive Immunizing Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Passive Immunizing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Passive Immunizing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Passive Immunizing Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Passive Immunizing Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Passive Immunizing Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Passive Immunizing Drugs Sales by Application (2027-2032) & (K Units) Table 53. Global Passive Immunizing Drugs Sales Market Share by Application (2021-2026) Table 54. Global Passive Immunizing Drugs Sales Market Share by Application (2027-2032) Table 55. Global Passive Immunizing Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Passive Immunizing Drugs Price by Application (2027-2032) & (US$/Unit) Table 57. Xingmeng Biopharmaceuticals (Suzhou) Company Information Table 58. Xingmeng Biopharmaceuticals (Suzhou) Business Overview Table 59. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Product Portfolio Table 61. Xingmeng Biopharmaceuticals (Suzhou) Recent Development Table 62. Wuhan Institute of Biological Products Company Information Table 63. Wuhan Institute of Biological Products Business Overview Table 64. Wuhan Institute of Biological Products Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Wuhan Institute of Biological Products Passive Immunizing Drugs Product Portfolio Table 66. Wuhan Institute of Biological Products Recent Development Table 67. Sichuan Yuanda Shuyang Pharmaceutical Company Information Table 68. Sichuan Yuanda Shuyang Pharmaceutical Business Overview Table 69. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Product Portfolio Table 71. Sichuan Yuanda Shuyang Pharmaceutical Recent Development Table 72. Shanxi Kangbao Biological Product Company Information Table 73. Shanxi Kangbao Biological Product Business Overview Table 74. Shanxi Kangbao Biological Product Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Shanxi Kangbao Biological Product Passive Immunizing Drugs Product Portfolio Table 76. Shanxi Kangbao Biological Product Recent Development Table 77. Sharon Bio-Medicine Company Information Table 78. Sharon Bio-Medicine Business Overview Table 79. Sharon Bio-Medicine Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sharon Bio-Medicine Passive Immunizing Drugs Product Portfolio Table 81. Sharon Bio-Medicine Recent Development Table 82. Hualan Biological Engineering Company Information Table 83. Hualan Biological Engineering Business Overview Table 84. Hualan Biological Engineering Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hualan Biological Engineering Passive Immunizing Drugs Product Portfolio Table 86. Hualan Biological Engineering Recent Development Table 87. North China Pharmaceutical Company Information Table 88. North China Pharmaceutical Business Overview Table 89. North China Pharmaceutical Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. North China Pharmaceutical Passive Immunizing Drugs Product Portfolio Table 91. North China Pharmaceutical Recent Development Table 92. Sinopharm Group Company Information Table 93. Sinopharm Group Business Overview Table 94. Sinopharm Group Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sinopharm Group Passive Immunizing Drugs Product Portfolio Table 96. Sinopharm Group Recent Development Table 97. Zydus Lifesciences Company Information Table 98. Zydus Lifesciences Business Overview Table 99. Zydus Lifesciences Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Zydus Lifesciences Passive Immunizing Drugs Product Portfolio Table 101. Zydus Lifesciences Recent Development Table 102. Serum Institute of India Company Information Table 103. Serum Institute of India Business Overview Table 104. Serum Institute of India Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Serum Institute of India Passive Immunizing Drugs Product Portfolio Table 106. Serum Institute of India Recent Development Table 107. Sanofi Pasteur Company Information Table 108. Sanofi Pasteur Business Overview Table 109. Sanofi Pasteur Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sanofi Pasteur Passive Immunizing Drugs Product Portfolio Table 111. Sanofi Pasteur Recent Development Table 112. Kedrion Biopharma Company Information Table 113. Kedrion Biopharma Business Overview Table 114. Kedrion Biopharma Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Kedrion Biopharma Passive Immunizing Drugs Product Portfolio Table 116. Kedrion Biopharma Recent Development Table 117. Kamada Company Information Table 118. Kamada Business Overview Table 119. Kamada Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Kamada Passive Immunizing Drugs Product Portfolio Table 121. Kamada Recent Development Table 122. Haffkine Bio-Pharmaceutical Company Information Table 123. Haffkine Bio-Pharmaceutical Business Overview Table 124. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Product Portfolio Table 126. Haffkine Bio-Pharmaceutical Recent Development Table 127. Grifols Company Information Table 128. Grifols Business Overview Table 129. Grifols Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Grifols Passive Immunizing Drugs Product Portfolio Table 131. Grifols Recent Development Table 132. Bharat Biotech Company Information Table 133. Bharat Biotech Business Overview Table 134. Bharat Biotech Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Bharat Biotech Passive Immunizing Drugs Product Portfolio Table 136. Bharat Biotech Recent Development Table 137. North America Passive Immunizing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Passive Immunizing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 140. North America Passive Immunizing Drugs Sales by Type (2027-2032) & (K Units) Table 141. North America Passive Immunizing Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 142. North America Passive Immunizing Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 143. North America Passive Immunizing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 144. North America Passive Immunizing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 145. North America Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 146. North America Passive Immunizing Drugs Sales by Application (2027-2032) & (K Units) Table 147. North America Passive Immunizing Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 148. North America Passive Immunizing Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 149. North America Passive Immunizing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America Passive Immunizing Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. North America Passive Immunizing Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. North America Passive Immunizing Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. North America Passive Immunizing Drugs Sales by Country (2021-2026) & (K Units) Table 154. North America Passive Immunizing Drugs Sales by Country (2027-2032) & (K Units) Table 155. North America Passive Immunizing Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 156. North America Passive Immunizing Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 157. United States Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 158. Canada Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 159. Mexico Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 160. Europe Passive Immunizing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 161. Europe Passive Immunizing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 162. Europe Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 163. Europe Passive Immunizing Drugs Sales by Type (2027-2032) & (K Units) Table 164. Europe Passive Immunizing Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 165. Europe Passive Immunizing Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 166. Europe Passive Immunizing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 167. Europe Passive Immunizing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 168. Europe Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 169. Europe Passive Immunizing Drugs Sales by Application (2027-2032) & (K Units) Table 170. Europe Passive Immunizing Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 171. Europe Passive Immunizing Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Europe Passive Immunizing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Europe Passive Immunizing Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Europe Passive Immunizing Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Europe Passive Immunizing Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 176. Europe Passive Immunizing Drugs Sales by Country (2021-2026) & (K Units) Table 177. Europe Passive Immunizing Drugs Sales by Country (2027-2032) & (K Units) Table 178. Europe Passive Immunizing Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 179. Europe Passive Immunizing Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 180. Germany Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 181. France Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 182. U.K. Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 183. Italy Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 184. Russia Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 185. Spain Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 186. Netherlands Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 187. Switzerland Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 188. Sweden Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 189. Poland Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 190. China Passive Immunizing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 191. China Passive Immunizing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 192. China Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 193. China Passive Immunizing Drugs Sales by Type (2027-2032) & (K Units) Table 194. China Passive Immunizing Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 195. China Passive Immunizing Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 196. China Passive Immunizing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 197. China Passive Immunizing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 198. China Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 199. China Passive Immunizing Drugs Sales by Application (2027-2032) & (K Units) Table 200. China Passive Immunizing Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 201. China Passive Immunizing Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Asia Passive Immunizing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Passive Immunizing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 205. Asia Passive Immunizing Drugs Sales by Type (2027-2032) & (K Units) Table 206. Asia Passive Immunizing Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 207. Asia Passive Immunizing Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 208. Asia Passive Immunizing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 209. Asia Passive Immunizing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 211. Asia Passive Immunizing Drugs Sales by Application (2027-2032) & (K Units) Table 212. Asia Passive Immunizing Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 213. Asia Passive Immunizing Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 214. Asia Passive Immunizing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Passive Immunizing Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Asia Passive Immunizing Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Asia Passive Immunizing Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 218. Asia Passive Immunizing Drugs Sales by Country (2021-2026) & (K Units) Table 219. Asia Passive Immunizing Drugs Sales by Country (2027-2032) & (K Units) Table 220. Asia Passive Immunizing Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 221. Asia Passive Immunizing Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 222. Japan Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 223. South Korea Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 224. India Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 225. Australia Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 226. Taiwan Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 227. Southeast Asia Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 228. SAMEA Passive Immunizing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 229. SAMEA Passive Immunizing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 230. SAMEA Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 231. SAMEA Passive Immunizing Drugs Sales by Type (2027-2032) & (K Units) Table 232. SAMEA Passive Immunizing Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 233. SAMEA Passive Immunizing Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 234. SAMEA Passive Immunizing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA Passive Immunizing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 237. SAMEA Passive Immunizing Drugs Sales by Application (2027-2032) & (K Units) Table 238. SAMEA Passive Immunizing Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 239. SAMEA Passive Immunizing Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 240. SAMEA Passive Immunizing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. SAMEA Passive Immunizing Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. SAMEA Passive Immunizing Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. SAMEA Passive Immunizing Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 244. SAMEA Passive Immunizing Drugs Sales by Country (2021-2026) & (K Units) Table 245. SAMEA Passive Immunizing Drugs Sales by Country (2027-2032) & (K Units) Table 246. SAMEA Passive Immunizing Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 247. SAMEA Passive Immunizing Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 248. Brazil Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 249. Argentina Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 250. Chile Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 251. Colombia Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 252. Peru Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 253. Saudi Arabia Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 254. Israel Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 255. UAE Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 256. Turkey Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 257. Iran Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 258. Egypt Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Passive Immunizing Drugs Distributors List Table 262. Passive Immunizing Drugs Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Passive Immunizing Drugs Image Figure 2. Global Passive Immunizing Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Passive Immunizing Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rabies Immunoglobulin Image Figure 5. Rabies Virus Monoclonal Antibody Image Figure 6. Anti-rabies Serum Image Figure 7. Global Passive Immunizing Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Passive Immunizing Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Category II Exposure Image Figure 10. Category III Exposure Image Figure 11. Global Passive Immunizing Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Passive Immunizing Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Passive Immunizing Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Passive Immunizing Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Passive Immunizing Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Passive Immunizing Drugs Sales (2021-2032) & (K Units) Figure 17. Global Passive Immunizing Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Passive Immunizing Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Passive Immunizing Drugs Sales YoY (2021-2032) & (K Units) Figure 20. Europe Passive Immunizing Drugs Sales YoY (2021-2032) & (K Units) Figure 21. China Passive Immunizing Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Passive Immunizing Drugs Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Passive Immunizing Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Global Passive Immunizing Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Passive Immunizing Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Passive Immunizing Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Passive Immunizing Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Passive Immunizing Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Passive Immunizing Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Passive Immunizing Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Passive Immunizing Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Passive Immunizing Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Passive Immunizing Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Passive Immunizing Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Passive Immunizing Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Passive Immunizing Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Passive Immunizing Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Passive Immunizing Drugs Revenue Share by Type (2021-2032) Figure 40. North America Passive Immunizing Drugs Sales Share by Type (2021-2032) Figure 41. North America Passive Immunizing Drugs Revenue Share by Application (2021-2032) Figure 42. North America Passive Immunizing Drugs Sales Share by Application (2021-2032) Figure 43. North America Passive Immunizing Drugs Revenue Share by Country (2021-2032) Figure 44. North America Passive Immunizing Drugs Sales Share by Country (2021-2032) Figure 45. Europe Passive Immunizing Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Passive Immunizing Drugs Sales Share by Type (2021-2032) Figure 47. Europe Passive Immunizing Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Passive Immunizing Drugs Sales Share by Application (2021-2032) Figure 49. Europe Passive Immunizing Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Passive Immunizing Drugs Sales Share by Country (2021-2032) Figure 51. China Passive Immunizing Drugs Revenue Share by Type (2021-2032) Figure 52. China Passive Immunizing Drugs Sales Share by Type (2021-2032) Figure 53. China Passive Immunizing Drugs Revenue Share by Application (2021-2032) Figure 54. China Passive Immunizing Drugs Sales Share by Application (2021-2032) Figure 55. Asia Passive Immunizing Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Passive Immunizing Drugs Sales Share by Type (2021-2032) Figure 57. Asia Passive Immunizing Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Passive Immunizing Drugs Sales Share by Application (2021-2032) Figure 59. Asia Passive Immunizing Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Passive Immunizing Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Passive Immunizing Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Passive Immunizing Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Passive Immunizing Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Passive Immunizing Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Passive Immunizing Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Passive Immunizing Drugs Sales Share by Country (2021-2032) Figure 67. Passive Immunizing Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Passive Immunizing Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Rabies Immunoglobulin
  • Rabies Virus Monoclonal Antibody
  • Anti-rabies Serum
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Xingmeng Biopharmaceuticals (Suzhou)
  • Wuhan Institute of Biological Products
  • Sichuan Yuanda Shuyang Pharmaceutical
  • Shanxi Kangbao Biological Product
  • Sharon Bio-Medicine
  • Hualan Biological Engineering
  • North China Pharmaceutical
  • Sinopharm Group
  • Zydus Lifesciences
  • Serum Institute of India
  • Sanofi Pasteur
  • Kedrion Biopharma
  • Kamada
  • Haffkine Bio-Pharmaceutical
  • Grifols
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Passive Immunizing Drugs Market by Type
  3. 1.2.1 Global Passive Immunizing Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rabies Immunoglobulin
  5. 1.2.3 Rabies Virus Monoclonal Antibody
  6. 1.2.4 Anti-rabies Serum
  7. 1.3 Passive Immunizing Drugs Market by Application
  8. 1.3.1 Global Passive Immunizing Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Category II Exposure
  10. 1.3.3 Category III Exposure
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Passive Immunizing Drugs Market Dynamics
  1. 2.1 Passive Immunizing Drugs Industry Trends
  2. 2.2 Passive Immunizing Drugs Industry Drivers
  3. 2.3 Passive Immunizing Drugs Industry Opportunities and Challenges
  4. 2.4 Passive Immunizing Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Passive Immunizing Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Passive Immunizing Drugs Revenue by Region
  3. 3.2.1 Global Passive Immunizing Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Passive Immunizing Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Passive Immunizing Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Passive Immunizing Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Passive Immunizing Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Passive Immunizing Drugs Sales by Region
  9. 3.4.1 Global Passive Immunizing Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Passive Immunizing Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Passive Immunizing Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Passive Immunizing Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Passive Immunizing Drugs Revenue by Manufacturers
  2. 4.1.1 Global Passive Immunizing Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Passive Immunizing Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Passive Immunizing Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Passive Immunizing Drugs Sales by Manufacturers
  6. 4.2.1 Global Passive Immunizing Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Passive Immunizing Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Passive Immunizing Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Passive Immunizing Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Passive Immunizing Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Passive Immunizing Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Passive Immunizing Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Passive Immunizing Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Passive Immunizing Drugs Market CR5 and HHI
  16. 4.8.2 2025 Passive Immunizing Drugs Tier 1, Tier 2, and Tier 3
5 Passive Immunizing Drugs Market by Type
  1. 5.1 Global Passive Immunizing Drugs Revenue by Type
  2. 5.1.1 Global Passive Immunizing Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Passive Immunizing Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Passive Immunizing Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Passive Immunizing Drugs Sales by Type
  6. 5.2.1 Global Passive Immunizing Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Passive Immunizing Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Passive Immunizing Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Passive Immunizing Drugs Price by Type
6 Passive Immunizing Drugs Market by Application
  1. 6.1 Global Passive Immunizing Drugs Revenue by Application
  2. 6.1.1 Global Passive Immunizing Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Passive Immunizing Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Passive Immunizing Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Passive Immunizing Drugs Sales by Application
  6. 6.2.1 Global Passive Immunizing Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Passive Immunizing Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Passive Immunizing Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Passive Immunizing Drugs Price by Application
7 Company Profiles
  1. 7.1 Xingmeng Biopharmaceuticals (Suzhou)
  2. 7.1.1 Xingmeng Biopharmaceuticals (Suzhou) Company Information
  3. 7.1.2 Xingmeng Biopharmaceuticals (Suzhou) Business Overview
  4. 7.1.3 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Product Portfolio
  6. 7.1.5 Xingmeng Biopharmaceuticals (Suzhou) Recent Developments
  7. 7.2 Wuhan Institute of Biological Products
  8. 7.2.1 Wuhan Institute of Biological Products Company Information
  9. 7.2.2 Wuhan Institute of Biological Products Business Overview
  10. 7.2.3 Wuhan Institute of Biological Products Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Wuhan Institute of Biological Products Passive Immunizing Drugs Product Portfolio
  12. 7.2.5 Wuhan Institute of Biological Products Recent Developments
  13. 7.3 Sichuan Yuanda Shuyang Pharmaceutical
  14. 7.3.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
  15. 7.3.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview
  16. 7.3.3 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Product Portfolio
  18. 7.3.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
  19. 7.4 Shanxi Kangbao Biological Product
  20. 7.4.1 Shanxi Kangbao Biological Product Company Information
  21. 7.4.2 Shanxi Kangbao Biological Product Business Overview
  22. 7.4.3 Shanxi Kangbao Biological Product Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanxi Kangbao Biological Product Passive Immunizing Drugs Product Portfolio
  24. 7.4.5 Shanxi Kangbao Biological Product Recent Developments
  25. 7.5 Sharon Bio-Medicine
  26. 7.5.1 Sharon Bio-Medicine Company Information
  27. 7.5.2 Sharon Bio-Medicine Business Overview
  28. 7.5.3 Sharon Bio-Medicine Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sharon Bio-Medicine Passive Immunizing Drugs Product Portfolio
  30. 7.5.5 Sharon Bio-Medicine Recent Developments
  31. 7.6 Hualan Biological Engineering
  32. 7.6.1 Hualan Biological Engineering Company Information
  33. 7.6.2 Hualan Biological Engineering Business Overview
  34. 7.6.3 Hualan Biological Engineering Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hualan Biological Engineering Passive Immunizing Drugs Product Portfolio
  36. 7.6.5 Hualan Biological Engineering Recent Developments
  37. 7.7 North China Pharmaceutical
  38. 7.7.1 North China Pharmaceutical Company Information
  39. 7.7.2 North China Pharmaceutical Business Overview
  40. 7.7.3 North China Pharmaceutical Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 North China Pharmaceutical Passive Immunizing Drugs Product Portfolio
  42. 7.7.5 North China Pharmaceutical Recent Developments
  43. 7.8 Sinopharm Group
  44. 7.8.1 Sinopharm Group Company Information
  45. 7.8.2 Sinopharm Group Business Overview
  46. 7.8.3 Sinopharm Group Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sinopharm Group Passive Immunizing Drugs Product Portfolio
  48. 7.8.5 Sinopharm Group Recent Developments
  49. 7.9 Zydus Lifesciences
  50. 7.9.1 Zydus Lifesciences Company Information
  51. 7.9.2 Zydus Lifesciences Business Overview
  52. 7.9.3 Zydus Lifesciences Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zydus Lifesciences Passive Immunizing Drugs Product Portfolio
  54. 7.9.5 Zydus Lifesciences Recent Developments
  55. 7.10 Serum Institute of India
  56. 7.10.1 Serum Institute of India Company Information
  57. 7.10.2 Serum Institute of India Business Overview
  58. 7.10.3 Serum Institute of India Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Serum Institute of India Passive Immunizing Drugs Product Portfolio
  60. 7.10.5 Serum Institute of India Recent Developments
  61. 7.11 Sanofi Pasteur
  62. 7.11.1 Sanofi Pasteur Company Information
  63. 7.11.2 Sanofi Pasteur Business Overview
  64. 7.11.3 Sanofi Pasteur Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sanofi Pasteur Passive Immunizing Drugs Product Portfolio
  66. 7.11.5 Sanofi Pasteur Recent Developments
  67. 7.12 Kedrion Biopharma
  68. 7.12.1 Kedrion Biopharma Company Information
  69. 7.12.2 Kedrion Biopharma Business Overview
  70. 7.12.3 Kedrion Biopharma Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Kedrion Biopharma Passive Immunizing Drugs Product Portfolio
  72. 7.12.5 Kedrion Biopharma Recent Developments
  73. 7.13 Kamada
  74. 7.13.1 Kamada Company Information
  75. 7.13.2 Kamada Business Overview
  76. 7.13.3 Kamada Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Kamada Passive Immunizing Drugs Product Portfolio
  78. 7.13.5 Kamada Recent Developments
  79. 7.14 Haffkine Bio-Pharmaceutical
  80. 7.14.1 Haffkine Bio-Pharmaceutical Company Information
  81. 7.14.2 Haffkine Bio-Pharmaceutical Business Overview
  82. 7.14.3 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Product Portfolio
  84. 7.14.5 Haffkine Bio-Pharmaceutical Recent Developments
  85. 7.15 Grifols
  86. 7.15.1 Grifols Company Information
  87. 7.15.2 Grifols Business Overview
  88. 7.15.3 Grifols Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Grifols Passive Immunizing Drugs Product Portfolio
  90. 7.15.5 Grifols Recent Developments
  91. 7.16 Bharat Biotech
  92. 7.16.1 Bharat Biotech Company Information
  93. 7.16.2 Bharat Biotech Business Overview
  94. 7.16.3 Bharat Biotech Passive Immunizing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Bharat Biotech Passive Immunizing Drugs Product Portfolio
  96. 7.16.5 Bharat Biotech Recent Developments
8 North America
  1. 8.1 North America Passive Immunizing Drugs Market Size by Type
  2. 8.1.1 North America Passive Immunizing Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Passive Immunizing Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Passive Immunizing Drugs Price by Type (2021-2032)
  5. 8.2 North America Passive Immunizing Drugs Market Size by Application
  6. 8.2.1 North America Passive Immunizing Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Passive Immunizing Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Passive Immunizing Drugs Price by Application (2021-2032)
  9. 8.3 North America Passive Immunizing Drugs Market Size by Country
  10. 8.3.1 North America Passive Immunizing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Passive Immunizing Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Passive Immunizing Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Passive Immunizing Drugs Market Size by Type
  2. 9.1.1 Europe Passive Immunizing Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Passive Immunizing Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Passive Immunizing Drugs Price by Type (2021-2032)
  5. 9.2 Europe Passive Immunizing Drugs Market Size by Application
  6. 9.2.1 Europe Passive Immunizing Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Passive Immunizing Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Passive Immunizing Drugs Price by Application (2021-2032)
  9. 9.3 Europe Passive Immunizing Drugs Market Size by Country
  10. 9.3.1 Europe Passive Immunizing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Passive Immunizing Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Passive Immunizing Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Passive Immunizing Drugs Market Size by Type
  2. 10.1.1 China Passive Immunizing Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Passive Immunizing Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Passive Immunizing Drugs Price by Type (2021-2032)
  5. 10.2 China Passive Immunizing Drugs Market Size by Application
  6. 10.2.1 China Passive Immunizing Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Passive Immunizing Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Passive Immunizing Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Passive Immunizing Drugs Market Size by Type
  2. 11.1.1 Asia Passive Immunizing Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Passive Immunizing Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Passive Immunizing Drugs Price by Type (2021-2032)
  5. 11.2 Asia Passive Immunizing Drugs Market Size by Application
  6. 11.2.1 Asia Passive Immunizing Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Passive Immunizing Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Passive Immunizing Drugs Price by Application (2021-2032)
  9. 11.3 Asia Passive Immunizing Drugs Market Size by Country
  10. 11.3.1 Asia Passive Immunizing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Passive Immunizing Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Passive Immunizing Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Passive Immunizing Drugs Market Size by Type
  2. 12.1.1 SAMEA Passive Immunizing Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Passive Immunizing Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Passive Immunizing Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Passive Immunizing Drugs Market Size by Application
  6. 12.2.1 SAMEA Passive Immunizing Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Passive Immunizing Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Passive Immunizing Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Passive Immunizing Drugs Market Size by Country
  10. 12.3.1 SAMEA Passive Immunizing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Passive Immunizing Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Passive Immunizing Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Passive Immunizing Drugs Value Chain Analysis
  2. 13.1.1 Passive Immunizing Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Passive Immunizing Drugs Production Mode & Process
  6. 13.2 Passive Immunizing Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Passive Immunizing Drugs Distributors
  9. 13.2.3 Passive Immunizing Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst